Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic factors associated with COVID-19 related severity in sickle cell disease.

Blood cells, molecules & diseases - 1 Dec 2021

Yurtsever Nalan, Nandi Vijay, Ziemba Yonah, Shi Patricia A

Abstract excerpt

BACKGROUND: Equipoise exists regarding sickle cell disease (SCD) as a risk factor for COVID-19 disease severity and variables that increase risk of COVID-19 severity in SCD. Given our health system's large SCD patient catchment, we analyzed our own experience in this regard. STUDY METHODS: Retrospective analysis of the clinical course and factors associated with need for hospitalization and ICU admission of SCD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to beta-Thalassemia
Share to Health Personnel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hospitalization

Share to Hydroxyurea

Share to Intensive Care Units

Share to SARS-CoV-2

Share to Sickle Cell Trait

Source

Open in PubMed Open full text

Identifiers

PMID: 34823201
DOI: 10.1016/j.bcmd.2021.102627
PMCID: PMC8595967

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic factors associated with COVID-19 related severity in sickle cell disease.PMID 34823201Read ↗

Clinical Spectrum of Sickle Cell Disease and COVID-19: Laboratory and Clinical Factors Associated with Morbidity and MortalitySemantic proximity Read ↗

Sickle Cell Disease and COVID-19: Susceptibility and SeveritySemantic proximity Read ↗

Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.Semantic proximity Read ↗

Definitions of the phenotypic manifestations of sickle cell disease.Semantic proximity Read ↗

Outcomes and Complications of Sickle Cell Disease among Hospitalized Paediatric Patients; A Retrospective Study in a Tertiary Hospital, TanzaniaSemantic proximity Read ↗

Genotype Differences and Hydroxyurea Utilization Among Adults With Moderate to Severe Sickle Cell Disease.Semantic proximity Read ↗

Mortality from Sickle Cell Disease in BrazilSemantic proximity Read ↗

COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNetSemantic proximity Read ↗

Risk of vaso-occlusive crisis requiring hospitalization in sickle cell disease patients in Brazil: retrospective cohort study of real-world dataSemantic proximity Read ↗

Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort.Semantic proximity Read ↗

ABO Phenotype and Clinical Correlates of COVID-19 Severity in Hospitalized PatientsSemantic proximity Read ↗

Prevalence and Significance of Elevated Cardiac Enzymes among Sickle Cell Disease Patients at King Abdulaziz University HospitalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.